Author

Bas L.A.M. Weusten 1

1 S

European Guideline on Achalasia – UEG and ESNM recommendations

Renske Anne Berndien Oude Nijhuis, Giovanni Zaninotto, Sabine Roman, Guy E. Boeckxstaens, Paul Fockens, Miranda Langendam, Andrew Plumb, André Smout, Eduardo Targarona, Alexander Trukhmanov, Bas L.A.M. Weusten, Arjan Bredenoord

FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH BARRETT ESOPHAGUS. A MULTI- CENTER CROSS SECTIONAL STUDY

Mirjam van der Ende, Pythia Nieuwkerk, Stephan van Stiphout, Robert Scheffer, Rogier de Ridder, Roos E. Pouw, Alaa Alkhalaf, Bas L.A.M. Weusten, Wouter L. Curvers, Erik Jan Schoon

FEASIBILITY, SAFETY, TOLERABILITY AND DOSE-RELATED EFFICACY OF A NOVEL SWIPE CRYOBALLOON ABLATION (90⁰-SCBA) DEVICE IN DYSPLASTIC BARRETT'S ESOPHAGUS

Anouk Overwater, Sanne N. van Munster, G.M. Raicu, C.A. Seldenrijk, Wouter B. Nagengast, Erik Jan Schoon, Jacques J.G.H.M. Bergman, Bas L.A.M. Weusten

First in-human (FIH) study on the Safety, Tolerability and Efficacy of the AquaMedical focal RF-vapor ablation (RFVA) system, for the eradication of Barrett's Esophagus (BE)

Sanne van Munster, Roos E. Pouw, Bas L.A.M. Weusten, Jacques J. Bergman

FIRST IN-HUMAN STUDY ON THE SAFETY, TOLERABILITY AND EFFICACY OF THE AQUAMEDICAL FOCAL RF-VAPOR ABLATION (RFVA) SYSTEM, FOR THE ERADICATION OF BARRETT'S ESOPHAGUS (BE): THE STEAM-BE DOSIMETRY STUDY

Sanne van Munster, Eva Verheij, Roos E. Pouw, Bas L.A.M. Weusten, Jacques J. Bergman

FIRST-IN-MAN PILOT STUDY: FEASIBILITY OF LASER MARKING IN BARRETT?S ESOPHAGUS WITH VOLUMETRIC LASER ENDOMICROSCOPY

AnneFré Swager, A J de Groof, Sybren L. Meijer, Bas L.A.M. Weusten, Wouter L. Curvers, Jacques J. Bergman

FOCAL C2 CRYOBALLOON (TM) ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA

Charlotte N. Frederiks, Anouk Overwater, Lorenza Alvarez Herrero, Alaa Alkhalaf, Raf Bisschops, Jacques J. Bergman, Roos E. Pouw, Alessandro Repici, Rehan J. Haidry, Torsten Beyna, Bas L.A.M. Weusten, Horst Neuhaus

HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS

Eva Verheij, Sanne van Munster, Esther Toes-Zoutendijk, Iris Lansdorp-Vogelaar, Esther A. Nieuwenhuis, Cary Cotton, Bas L.A.M. Weusten, Lorenza Alvarez Herrero, Alaa Alkhalaf, Boudewijn Edwin Schenk, Erik J. Schoon, Wouter L. Curvers, Arjun D. Koch, Pieter Jan de Jonge, Thjon J. Tang, Wouter B. Nagengast, Jessie Westerhof;;

HOW TO HANDLE TISSUE SPECIMENS AFTER ENDOSCOPIC MUCOSAL RESECTION FOR BARRETT'S ESOPHAGUS RELATED NEOPLASIA: A MULTICENTER RANDOMIZED TRIAL COMPARING THREE SPECIMEN HANDLING METHODS

Anouk Overwater, Kim E. van der Meulen, Hannah T. Künzli, Erik Jan Schoon, Jacques J. G. H. M. Bergman, G.M. Raicu, Cornelis A. Seldenrijk, Bas L.A.M. Weusten

How to stage BE cancer: EUS or endoscopic removal

Bas L.A.M. Weusten

Item 21 - 30 / 84
1 2
3
4 5 6 7 8 9